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Abstract
We assess five years of usage of the major genome-wide collections of mutants from
Saccharomyces cerevisiae: single deletion mutants, double mutants conferring ‘synthetic’ lethality
and the ‘TRIPLES’ collection of mutants obtained by random transposon insertion. Over 100
experimental conditions have been tested and more than 5,000 novel phenotypic traits have been
assigned to yeast genes using these collections. 
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In April 1996, the completely annotated genome sequence of
the yeast Saccharomyces cerevisiae was made publicly
available [1,2], the first eukaryotic genome sequence to be
completed. Eight years later, thanks to the united efforts of
the large yeast research community and to the unique
genetic and physiological properties of yeast, this humble
servant of mankind provides by far the best annotated
eukaryotic genome [3]. The completeness of the yeast
genome sequence has allowed the development of many
novel tools for analyzing all molecular components of the
cell and their interactions. These tools include three high-
throughput collections of mutants that were first produced
in 1999 and that have been analyzed in the five years since
then. Here, we review the uses of these collections and their
contribution to the identification of the components of basic
physiological and developmental pathways of S. cerevisiae.
The yeast deletion mutant collection
A set of over 20,000 knockout strains was created by a con-
sortium of European and North American laboratories [4,5].
The collection currently contains homozygous and heterozy-
gous diploid strains corresponding to deletions of each of
5,916 genes (including 1,159 essential genes) and one
haploid strain of each mating type for every non-essential
gene (4,757 genes). Each knockout strain is marked by two
unique 20-nucleotide ‘bar codes’, allowing quantitative and
qualitative identification by DNA microarray hybridization
of each strain in the pools used to assess the strains under
different growth conditions (see Figure 1). The original
article [4] describing this collection has been cited more
then 560 times in the five years since its publication, accord-
ing to the ISI Web of Science [6]. The complete collection of
strains can be obtained at low cost from Euroscarf [7], ATCC
[8] and Invitrogen [9].
The deletion collection has been used in dozens of novel
exhaustive screens for phenotypes that occur under a variety
of physiological conditions; these include growth in minimal
medium, in high salt and low salt, in galactose or sorbitol, at
pH 8, after heat or cold shock, under stress by hydrogen per-
oxide (all in [10]); growth on non-fermentable carbon sub-
strates [11], in saline conditions [12] or after treatment by
ionizing radiation or DNA-damaging agents [13-17]; and the
collection has also been screened for defects in meiosis,
sporulation and germination [18,19]. This approach has
uncovered numerous new putative components of well-
known pathways; for instance, the number of genes known
to have sporulation or germination phenotypes when deleted
has been doubled by these analyses [18]. 
More sophisticated screens, for example for suppressors of
the accumulation of mutations [20], have been developed
more recently, as well as screens involving transformation ofthe deletion strains in order to identify genes needed for
non-homologous DNA end-joining [21]. Novel protocols
requiring individual transformations of each mutant have
allowed the identification of host factors that influence the
fate of the Ty family of long-terminal-repeat retrotranspos-
able elements [22] and of genes involved in the unfolded
protein response induced by heterologous introduction of
mutant human Huntingtin protein or fragments of  -synu-
clein, both of which form disease-associated aggregates [23].
Similarly, proteins that interfere with the assembly of endo-
plasmic-reticulum structures termed karmellae, which are
induced by elevated levels of HMG-CoA reductase under
specific growth and genetic conditions, have been identified
using the collection [24]. Several morphological screens
have been developed, for example for defects in the selection
of the bipolar bud site [25], in cell-size distribution [26,27],
in cell morphology [28] and in meiotic chromosomal segre-
gation [29]. Another approach is the screening of individual
colonies. For instance, mis-sorting and secretion of vacuolar
carboxypeptidase Y were detected by colony immunoblotting
[30]. A second example of colony screening is the transfor-
mation of each single-deletion strain to express viral repli-
case proteins and an RNA replication template in which the
capsid gene was replaced by a luciferase reporter gene,
which was used to monitor viral expression in yeast colonies
[31]. Finally, to identify the genes affecting glycogen storage,
the deletion mutant colonies were blotted and stained by
iodine vapor; the intensity of coloration allowed assessment
of glycogen accumulation [32].
Use of the yeast deletion collection in screens for
synthetic lethal mutants and to study drug targets 
Synthetic lethality is the phenomenon that occurs when two
mutations that are each viable are combined and the double
mutant is lethal. A method has been developed for the sys-
tematic construction of double mutants, which is called syn-
thetic genetic array analysis (SGA) [33,34]. Haploid strains
with mutations in non-essential genes were crossed to an
array of the whole haploid deletion collection; the resulting
diploid cells were made to sporulate and the lethal combina-
tions identified, indicating the existence of essential interac-
tions between gene products. In a first SGA screen using
eight query genes, 291 interactions among 204 genes were
identified [33]. Three years later [34], the search was
expanded to 132 query genes, and 4,000 interactions were
identified among 1,000 genes with roles in cytoskeletal orga-
nization, cell-wall biosynthesis, microtubule-based chromo-
some segregation and DNA metabolism.
A more recent development of this approach is the use of
DNA-DNA hybridization protocols to assess lethality,
termed ‘synthetic lethality analysis by microarray’ (SLAM).
In this method, a pool of haploid deletion strains is trans-
formed with a cassette that replaces the gene of interest with
either a deletion construct or the wild-type form. Transfor-
mants are pooled and genomic DNA is isolated; the barcodes
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Figure 1
Construction and screening of the yeast deletion strain collection.
(a) The cassette used consists of a kanamycin-resistance gene (KanMX4)
flanked by two tags (also called barcodes), the UPTAG and the
DOWNTAG, which are unique to each gene. The yeast DNA 5  and 3 
to the barcodes is homologous to yeast DNA flanking the gene to be
deleted. After homologous recombination, the gene is replaced by the
cassette sequences, including the barcodes. (b) Screening the deletion
strains for differences in fitness under selective conditions. Selection leads
to an increase in the proportion of some strains in the culture and a
decrease of others; these changes can be detected by probing a
microarray containing the sequences complementary to the barcodes. A
stronger signal, indicating a higher level of a barcode in the RNA
extracted from the culture, shows strains that have increased in
frequency after selection. Adapted with permission from [71].
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(b)are amplified by PCR and labeled with either Cy3 (green) or
Cy5 (red) fluorescent dyes; and hybridization to an array
containing all the deletion tags allows identification of the
synthetic-lethal combinations (which are missing). The
SLAM method has been validated by identifying members of
the DNA helicase interaction network [35]. Synthetic genetic
arrays have also been used for high-resolution genetic
mapping of suppressor mutations [36]; this method, termed
SGA mapping (SGAM), is in principle also applicable to the
analysis of multigenic traits.
The yeast deletion collection has also been used to identify
members of the pathways modified by more than 25 differ-
ent chemical ligands. This approach has identified the L-car-
nitine transporter Agp2p as a novel transporter of bleomycin
in yeast, implicating membrane transport as a key determi-
nant of resistance to this widely used anticancer agent [37].
In another study, the transcription factor Rpn4p was shown
to compensate for proteasome inhibition by PS-341, a drug
that is being studied as a treatment for cancer [38]. Other
ligands tested include the phosphatidyl kinase inhibitor
wortmannin [39]; anticancer agents [10,37,40,41]; antifun-
gal agents including nystatin and calcofluor [10,41]; antibi-
otics including hygromycin B [42] and rapamycin [43];
statins (a class of drugs that lower cholesterol), the smooth
muscle relaxant alverine citrate, the local anaesthetic dyclo-
nine, yeast K1 killer toxin [44], 6-azauracil (a drug that
depresses cellular nucleoside triphosphate levels [45]) and
even the detergent sodium dodecyl sulfate [44].
Major scientific contributions arising from the use of
the yeast deletion collection 
In a total of 33 publications that have used the deletion col-
lection, in which over 100 different conditions were explored,
more then 5,000 genes were attributed a phenotype (see
Table 1 for an overview). Many of these genes were not previ-
ously known to contribute to the pathways scrutinized, even
though in many cases - such as in studies of sporulation, the
cell cycle, radiation damage and growth in defined media -
there had previously been apparently exhaustive classical
mutagenesis or DNA microarray screens. Altogether, these
analyses have shown 71 genes previously thought to be non-
essential to have a nonviable phenotype [46]; and the system-
atic deletion approach has been claimed to be five-fold more
sensitive then a microarray gene-expression analysis for
finding genes involved in pathways of interest [11]. 
Some new phenotypes have emerged from these analyses,
although many known phenotypes have not yet been
explored [47]. As an example of recent novel information
provided by the systematic-deletion approach, over 100 new
genes resulting in a defective bipolar budding pattern [25]
have been identified. Other examples are the identification
of a new putative bleomycin transporter [37]; the NEJ1 gene
involved in non-homologous DNA end-joining and claimed
to be one of the guardians of the cancer cells [21]; and 52
genes, the deletion of which causes lethality in yeast trans-
fected with a fragment of heterologous human Huntingtin
[23]. The latter set, which includes genes involved in lipid
metabolism, vesicle transport and of unknown function, may
help to define the still poorly defined pathway termed the
unfolded protein response [23].
Uncertainties in the results obtained from systematic
deletion mutants 
The yeast deletion collection allows powerful novel screens
and has revealed many novel components of complex meta-
bolic and developmental pathways. The data produced
should be examined with great care, however, as there are
several problems with the use of the collection (for further
details, see two reviews by Elisabeth Winzeler [46,48]). A
first issue is that the collection is incomplete, as a few
hundred genes were missed in the first annotation of the
genome that was used as the basis of the deletions (see
updates of yeast genome data in Saccharomyces genome
database (SGD) [49]). Moreover, relative amounts of some
deleted strains may have been distributed unequally during
the initial creation of the pools and further amplified [4].
Secondly, there can be problems with mutations or varia-
tions elsewhere in the genome that affect the phenotype. For
instance, because the transformation procedure that was
used to create the deletion library is a mutagenic event,
mutations in sites some distance away from the intended
deletion might be present in some strains [50]. Also, up to
8% of the deleted strains are known to retain a wild-type
copy of the targeted gene, presumably because of aneuploidy
or some duplication event [50]. Even in diploid strains,
mutations that apparently have no phenotype may in fact
modify the phenotype of other mutations in subtle ways (a
phenomenon termed haploinsufficiency) [51].
When deletions are moved into a different genetic back-
ground, their phenotypes may change; for instance, up to
18% of synthetic-lethal interactions were not confirmed in
different backgrounds [33,46]. Another source of discrep-
ancy might be genetic variation among the individual iso-
lates of the strains that are amplified under given selective
conditions. For instance, the phenotype for a given mutant
strain can be masked by extracellular complementation by a
protein product of another strain in the pool. 
Other factors are related to the use of the barcodes. Their
presence may modify the phenotype or, conversely, the
stress created by the knockout procedure may mutagenize
the barcode. About 17% of the 4,600 homozygous strains in
the collection have a hybridization signal similar to that of
the background. Moreover, trivial technical factors may
affect the hybridization data, for example when the wrong
piece of DNA is deposited on the microarray or when the tag
modifies the secondary structures and thus causes poor
hybridization. Also, some published datasets have too few
repetitions of experiments to be statistically valid.
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Table 1
Screens performed so far on the yeast deletion strain collection and transposon-insertion collection 
Number of genes responding 
Condition, treatment or phenotype  to the treatments* References
Phenotype screens of the deletion collection
Fitness after growth on minimal medium, high salt, low salt, galactose, sorbitol, pH 8, heat shock,  ? [10]
cold shock, or hydrogen peroxide
Growth on non-fermentable carbon substrates 466 [11]
Response to DNA-damaging agents, ionizing radiation, UV radiation, cisplatin, or hydrogen peroxide > 170 [13-16]
Chemical DNA damage (methane sulfonate sensitivity) 103 [17]
Enhanced sporulation proficiency 102  [18,19]
Sporulation defects 261 [18,19]
Post-germination defects 158 [18,19]
Genes essential for sporulation  334 [18,19]
Saline response About 500 [12]
Suppression of the accumulation of mutations 33 [20]
Non-homologous DNA end-joining About 30 [21]
Ty1 retrotransposition cycle 101 [22]
Response to the introduction of human Huntingtin or  -synuclein fragments (unfolded  52 / 86 [23]
protein response)
Karmellae assembly 120 [24]
Bipolar bud-site selection 127 [25]
Cell-size distribution 500 [26,27]
Altered cell morphology ? [28]
Meiotic chromosomal segregation ? [29]
Vacuolar protein sorting 146 [30]
Host genes affecting replication of a positive-strand RNA virus 100 [31]
Glycogen storage (low, high) 324, 242 [32]
Sensitivity of the deletion collection to drugs or chemicals
Rapamycin 106 [43]
PS-341 ? [38]
Bleomycin (hypersensitivity, resistance) 231, 5 [37,40]
Amoxillin, penicillin, rifampin, vancomycin, (oxy)tetracycline, or gentamicin 23 [42]
Anticancer, antifungal agents, statins, alverine citrate, dyclonine, or nystatin About 10 [10,41]
K1 killer toxin, hygromycin B, calcofluor or sodium dodecyl sulfate 268 [44]
6-Azauracil  42 [45]
Wortmannin (resistance, sensitivity) 591, 476 [39]
Phenotypes of transposon-insertion libraries
Phenotypes under 20 conditions, expression levels and subcellular localization (TRIPLES database)  ? [55]
High salt 31 [58]
Survival of hypo-osmotic shock and growth at 15°C 10 [58]
Ethanol tolerance and cell-wall modifications 5 [59]
Nitrogen starvation, invasive or filamentous growth and sporulation About 105 [60]
*The number of open reading frames responding to the relevant screen is reported whenever this information could be deduced from the relevant
article; ? indicates that the information could not be deduced.These and other problems concerning the specificity and
sensitivity of the screen used must be taken into account
when interpreting data obtained using the yeast deletion col-
lection. As a gross estimate, over one third of the data may
consist of false positives or false negatives. As a golden rule,
therefore, the data from a primary screen of the collection
should always be confirmed by independent approaches.
Collections of strains mutated using
transposons
Transposons are mobile genetic elements that can be used to
disrupt genes in a non-targeted fashion. Insertional mutage-
nesis using transposons can disrupt non-coding as well as
coding regions and can lead to partial loss or gain of func-
tion; it is thus complementary to deletion of genes [52]. The
‘mini-Mu’ transposon modified for insertional mutagenesis
in yeast was pioneered by Daignan-Fornier and Bolotin-
Fukuhara [53]. Ross-Macdonald et al. [52] used a version of
the same transposon including a reporter gene (lacZ), an
epitope tag (encoding hemagglutinin) and selectable
markers for yeast and bacteria to perform random transpo-
son mutagenesis. The approach uses a minitransposon that
was introduced into the yeast genome by a two step method:
a yeast genomic DNA library was mutagenized in
Escherichia coli using the minitransposon; the library plas-
mids were then cut to excise the yeast genomic DNA with the
transposon insertion, which was transformed into diploid
yeast, replacing one chromosomal copy by homologous
recombination [52]. This transposon-mutagenesis system
can be used for the analysis of gene expression, detection of
subcellular localization and identification of phenotypes
caused by the insertion, and the transposon can be deleted
using the Cre-LoxP recombinase system, removing the selec-
table marker. The insertion point in the genome can be
determined for each mutant by sequencing outwards from
the transposon sequence into the surrounding yeast
sequences. The article describing the first such screen [52]
has been cited 209 times in the five years since its publica-
tion [6]. The collection of transposon-inserted strains
created in this work [52] is available free of charge from
Michael Snyder’s laboratory [54].
A database called ‘transposon-insertion phenotypes, local-
ization and expression in Saccharomyces cerevisiae’
(TRIPLES) [55,56] contains the results obtained from
exploiting the mutants obtained by the transposon-insertion
approach. A total of 240,768 yeast insertional mutants were
screened for transposon-encoded  -galactosidase activity,
and a collection of 28,428 yeast strains was generated that
produce   -galactosidase under conditions of vegetative
growth and/or sporulation. The insertion point of 23,191 of
these strains has been sequenced, identifying 3,750 different
yeast genes, and the subcellular localization of 2,744 differ-
ent yeast proteins has been documented (A. Kumar, per-
sonal communication).
The transposon-insertion collection [52,54] has been used to
identify genes involved in sporulation and vegetative growth.
Analysis of the collection has also identified 137 new genes
that were not originally annotated by the yeast genome
sequencing consortium [57]. Ferreira et al. [58] have used
the collection - which was produced in the S288C strain used
to sequence the yeast genome [52] - to mutagenize the
W303-1A strain (which is known to be more responsive to
gene inactivation than the S288C). Ferreira et al. [58] iden-
tified genes required for growth in high-salt medium (61
insertions in 31 genes) and survival of hypo-osmotic shock
and growth at 15°C (31 insertion in 10 genes). A similar
approach was also used by Takahashi et al. [59] to screen in
other strains for ethanol tolerance and modification of the
cell wall, and by Suzuki et al. [60] to screen for the effects of
insertions on the response to nitrogen starvation, on inva-
sive or filamentous growth and on sporulation.
Other approaches for insertional mutagenesis have also been
applied to yeast. Firstly, instead of bacterial mini-Mu trans-
posons, T-DNA from Agrobacterium tumefaciens has been
used to mutagenize yeast on a genome-wide scale [61]. A
second approach is the use of non-homologous insertion of
DNA cassettes not derived from mobile elements. This
process, which exploits the cellular machinery that normally
repairs DNA double-strand breaks by non-homologous end
joining, is increased by gamma irradiation [62]. Thirdly,
Blanc and Adams [63] used mutations resulting from inser-
tion of the Ty1 transposon to identify yeast mutations that
generate evolutionarily significant phenotypes by causing
small but positive increments of fitness. Finally, an applica-
tion of transposon mutagenesis called direct allele replace-
ment technology (DART) allows rapid transfer of any
insertion allele into any strain [64]. A transposon library
consisting of a collection of plasmids containing yeast
genomic DNA with transposon insertions is sequenced to
identify the exact insertion point in the yeast genomic DNA
[64]. After excision from the plasmid, the yeast genomic
DNA containing the transposon is used to transform a yeast
strain of choice by homologous recombination. The proce-
dure was validated by identification of 29 insertions into 17
genes involved in apical growth [64].
Insertional mutagenesis using transposons has several
potential advantages over targeted deletion: for instance,
insertion occurs in the non-coding as well as in the coding
segments, so regulatory regions and other non-genic regions
can be disrupted. Moreover, depending on the site of inser-
tion, transposon mutagenesis may lead to partial loss of
function or gain of function and hence to the identification
of novel functions that would not be found from studies of
complete knockouts of genes [52]. Conditional alleles may
be generated, as well as mutants in promoter or terminal
regions. Also, apart from phenotype analysis of the muta-
tion, the level of expression of the targeted gene can be mea-
sured in vivo and the subcellular localization of its product
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son insertions are not random, and this method may there-
fore never cover all the genes in the genome. Also, several of
the problems that were mentioned above for the analysis of
the yeast deletion collection apply equally to the transposon
mutant collections, including the observation that pheno-
types are often very strongly background-dependent.
Other genome-wide mutant collections and
their uses
Several databases have been developed to catalog the subcel-
lular localizations of yeast proteins as identified by fluores-
cence microscopy. The yeast protein localization database
[65,66] describes the results obtained using a library of yeast
genes fused to a green fluorescent protein (GFP) reporter.
The TRIPLES database [55,56] includes the use of the trans-
poson-insertion libraries to determine protein localization
for 5,504 insertions. The yeast GFP fusion localization data-
base [67,68] presents the localization of 4,156 proteins into
22 distinct subcellular locations, as determined using a
library of GFP-tagged proteins compared with reference
strains expressing proteins of known localization tagged
with red fluorescent protein (the strains used are available
from Invitrogen [9]). 
In a recent study [69], an exhaustive global analysis of
protein expression in yeast was reported. Each open
reading frame was marked by an insertion cassette consist-
ing of a modified version of the tandem affinity purification
(TAP) tag, a yeast selectable marker to drive homologous
recombination, and regions homologous to yeast genes. The
level of expression of each protein was determined by very
sensitive western-blotting analysis that could detect less
than 50 protein molecules per cell. The level of expression
of 4,251 gene products was identified in exponential growth
conditions [69].
Like the sequencing of the yeast genome, the construction of
the single and double deletion libraries and that of the major
transposon insertion library has required a considerable
investment by the international yeast research community.
The three original papers [4,33,52] presenting the libraries
have a total of 83 authors, funded by public agencies from
the USA, from the European Union and from Canada. Was
this effort worthwhile?
Over the last five years, the three seminal papers have been
cited more than 950 times [6]. We have found over 50 exper-
imental papers reporting on different phenotypic screens
carried out with these genome-wide libraries. More than 100
experimental conditions have been tested, representing near
a million individual mutant screens. We estimate that more
than 5,000 novel phenotypic traits have been assigned to
yeast genes of known or unknown molecular functions. This
undoubtedly represents a considerable amount of progress
towards the ultimate goal of a full description of the func-
tions and interactions of all the molecular components of a
basic eukaryotic cell. Several recent improvements of the use
of the original genome-wide mutant libraries have been
reported, such as the DART [64] and SLAM [35] approaches
described above. New genome-wide libraries using more
sensitive protein tagging are being developed [69] for global
measurements of protein levels or subcellular expression. In
all this work, yeast continues to be a very convenient test-
bed for the development of novel high-throughput tools that
rely on the availability of the complete genome sequence.
But a word of caution is appropriate. As was the case for
other high-throughput tools that were also pioneered using
yeast, such as two-hybrid protein-interaction screening,
DNA-hybridization microarrays and proteomic analyses, the
information provided by large screens of genome-wide
libraries contains an appreciable number of false-positive
and false-negative data points. It is therefore essential to
confirm each result by several independent approaches. Ulti-
mately, we will have to return to ‘reductionist’ biochemical
approaches to demonstrate fully the molecular function sug-
gested by a large primary screen.
Finally, there is an urgent need to build databases to collect
and organize all the data obtained from all the large screen-
ing approaches. The SGD [49] and the Munich information
center for protein sequences (MIPS) database [70] are
making good progress in this respect. The authors of these
databases should, however, be encouraged to further
develop procedures that take into account the difficult
assessment of the uncertainties associated with much of the
data. Here again, yeast is expected to become a pioneer.
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